Here's how an activist investor is threatening a Peninsula drug maker's merger plans. And the drama introduces a potential ...

A Chinese biotech that became popular by co-developing an anti-Covid drug has filed for a Hong Kong stock market listing.

Celanese Co. (NYSE:CE – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 11,714 put options on the company. This is an increase of 317% compared to the ...